Arcutis Biotherapeutics (ARQT) Stock Price & Financial Analysis
Arcutis Biotherapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Arcutis Biotherapeutics
What is the current stock price for ARQT?
As of the latest trading session, ARQT stock trades at $26.21. The 52-week range is $13.06–$31.77, with a day range of $25.43–$27.00.
What is the P/E ratio for ARQT?
The P/E ratio (Price-to-Earnings) for ARQT is shown in the Key Statistics section. This valuation metric helps compare Arcutis Biotherapeutics, Inc. to industry peers.
Does ARQT pay dividends?
Arcutis Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARQT?
Based on 6 analysts, the consensus for ARQT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ARQT?
Arcutis Biotherapeutics's market capitalization is $3.39B, classifying it as a mid-cap company. Arcutis Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.